As per MRFR Analysis, the Blood Testing Market was valued at 27.66 USD Billion in 2023 and is projected to grow to 45.1 USD Billion by 2035. The market is driven by the increasing prevalence of chronic diseases, technological advancements, and a rising demand for personalized medicine. Key players are focusing on innovations in testing technologies, enhancing diagnostic accuracy and efficiency.
The Blood Testing Market is characterized by several key trends driving its growth.
Key players include Abbott Laboratories, BioRad Laboratories Inc, Becton Dickinson and Company, Hologic Inc, Mindray Medical International Limited, Thermo Fisher Scientific Inc, Danaher Corporation, Roche Holding AG, Sysmex Corporation, Mayo Clinic Laboratories, Hemocue AB, Ortho Clinical Diagnostics, Grifols SA, Beckman Coulter Inc, Siemens Healthineers.
The Blood Testing Market CAGR (growth rate) is expected to be around 4.16% during the forecast period (2025 - 2035).
The Blood Testing Market is experiencing significant shifts driven by various factors. Numerous important market drivers are propelling the substantial growth of the Blood Testing Market. The growing incidence of chronic illnesses is one of the main causes.
This has raised the need for routine blood tests in order to diagnose and treat them in a timely manner. Additionally, people are being encouraged to have regular blood tests to keep an eye on their health due to the increased awareness of preventative healthcare.
The market is growing as a result of technological developments in blood testing, such as the creation of point-of-care testing equipment and laboratory automation. By incorporating machine learning and artificial intelligence into blood testing procedures, commercial opportunities can be seized.
These technologies can increase test findings' speed, accuracy, and efficiency, which will appeal to patients and healthcare professionals alike. Furthermore, because of the growing demand for better healthcare infrastructure and diagnostic access, emerging markets in underdeveloped nations offer substantial development prospects.
Recent trends show that home-based blood testing options are becoming more and more popular. This is mostly due to the trend of telehealth services and the need for convenience, particularly after the COVID-19 epidemic spurred the adoption of remote healthcare solutions.
Self-testing kit innovations are increasing accessibility and enabling people to take control of their health from home. Personalized medicine is also becoming more and more popular, and blood tests can provide unique insights that improve treatment results.
These trends show that the worldwide blood testing market is characterized by a dynamic landscape driven by both technology breakthroughs and changing customer needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Blood Testing Market is significantly driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer. According to the World Health Organization, there are approximately 35 million new cases worldwide in 2014.
This represents a critical need for reliable blood testing solutions. Major organizations like the American Diabetes Association and the American Heart Association are actively promoting awareness and facilitating improved blood testing methods to manage these conditions.
As healthcare systems globally prioritize early diagnosis and continuous monitoring of chronic diseases, the demand for advanced blood testing technologies continues to surge. This trend provides a substantial growth opportunity for the Blood Testing Market.
This is especially true as healthcare expenditures rise and the population ages in various regions across the globe.
Technological advancements in diagnostic tools and methods play a vital role in driving the growth of the Blood Testing Market. Innovations such as point-of-care testing, molecular diagnostics, and automation in laboratories enhance accuracy and provide faster results to healthcare professionals.
The Healthcare Information and Management Systems Society emphasizes that integration of cutting-edge technology in laboratory practices is crucial for improving patient outcomes, ultimately affecting an estimated 3 billion testing procedures globally each year.
Leading companies like Roche Diagnostics and Abbott Laboratories are investing heavily in Research and Development (R&D) to create a favorable environment for the Blood Testing Market.
The growing trend of personalized medicine significantly influences the Blood Testing Market. Personalized medicine tailors treatment based on individual patient characteristics, particularly genetic factors, making blood tests a critical component in the delivery of personalized healthcare.
The National Institutes of Health stated that precision medicine could potentially advance patient care in oncology, suggesting that about 90% of new cancer therapies are targeted therapies based on genetic testing.
Companies such as Illumina and Novartis are at the forefront of developing personalized blood tests that not only improve diagnostic precision but also enhance therapeutic decision-making. This accelerated shift towards individualized healthcare is expected to substantially elevate the demand within the Blood Testing Market in the coming years.
The Blood Testing Market was an essential sector characterized by its diverse test types, catering to various healthcare needs. Among the various test types, Complete Blood Count held a notable share, with a value of 5.76 USD Billion in 2024.
It is likely to rise to 9.15 USD Billion by 2035. The test type played a crucial role in diagnosing a wide range of conditions, making it a preferred choice among healthcare providers.
Blood Chemistry Tests contributed substantially to the market as well, valued at 9.98 USD Billion in 2024 and predicted to increase to 15.55 USD Billion in 2035. These tests were vital for evaluating organ function and metabolic disorders.
Thus, they dominated the market due to their comprehensive insights into patient health. Blood Glucose Tests, valued at 4.31 USD Billion in 2024 and anticipated to reach 6.64 USD Billion by 2035, held significant relevance in managing diabetes.
They are increasingly being utilized in routine check-ups, thus showcasing its enduring importance. Coagulation Tests, valued at 3.42 USD Billion in 2024 and projected at 5.35 USD Billion in 2035, played a critical role in assessing blood clotting disorders.
This demonstrates its significance in surgical and trauma care, hence ensuring its steady demand. Lastly, Blood Typing Tests, with a valuation of 5.34 USD Billion in 2024, expected to rise to 8.41 USD Billion by 2035, served as a foundational service in transfusions.
This also includes organ transplants, reflecting their important role in surgical procedures and emergency care. The structured segmentation of the Blood Testing Market, with diverse test types, reflected the multifaceted nature of blood testing in clinical practices.
This is driving a projected steady market growth amid increasing healthcare needs and advancements in technology. The combined value of these tests illustrated a robust demand driven by both clinical requirements and the global rise in health awareness.
This highlights the relevance of each test type in maintaining overall health and well-being.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The market encompasses various key areas including Hospitals, Diagnostic Laboratories, Home Care Settings, and Research Institutions, each playing a crucial role. Hospitals dominate the landscape due to their extensive range of diagnostic services.
They provide vital health information for effective treatment. Diagnostic Laboratories also hold a significant share, as they are the primary centers for blood analysis, catering to an increasing demand for rapid and accurate testing.
The rise of Home Care Settings supports the trend towards patient-centric care, allowing for convenient testing solutions outside conventional facilities. Additionally, Research Institutions contribute to advancements in technology and methodologies, fostering innovation within the blood testing arena.
The Blood Testing Market statistics underscore the importance of these segments in meeting global healthcare demands, highlighting a growing emphasis on efficiency, accessibility, and precision in diagnostics. Overall, the market growth reflects increasing investments in healthcare infrastructure.
This also includes the demand for accurate diagnostic services worldwide.
The segment consists of various components that play crucial roles in the effectiveness of blood testing processes. The importance of reagents cannot be overstated, as they are essential for accurate diagnostic results and are vital in laboratories worldwide.
Consumables also hold a significant share within the market, ensuring smooth testing operations. Meanwhile, instruments represent the backbone of blood testing procedures, encompassing a wide range of advanced devices that provide precise measurements and results.
Furthermore, software solutions enhance the efficiency of blood testing laboratories, facilitating data management and analysis, as well as improving operational workflows. The trends reflecting the growth of this market are driven by increasing global awareness.
This includes awareness about blood-related diseases, technological advancements in testing instruments, and a rising demand for automation in laboratories. Along with opportunities such as expanding healthcare infrastructure in various regions, challenges exist.
These include the need for stringent regulatory compliance and cost management. The Blood Testing Market segmentation highlights the diverse elements that collectively contribute to improved healthcare outcomes globally.
The Blood Testing Market was poised for significant growth across various regions, with North America holding a majority share valued at 12.0 USD Billion by 2035. This region's dominance was attributed to advanced healthcare infrastructure and high investment in Research and Development.
Europe followed closely with a valuation of 7.5 USD Billion by 2035, driven by increasing awareness regarding health screenings. APAC presented a noteworthy opportunity, valued at 6.5 USD Billion in 2024, with projections of 10.3 USD Billion by 2035.
This is due to rising population and improving healthcare spending. South America, while smaller markets, showed promising growth from 1.5 USD Billion to 2.8 USD Billion and from 1.31 USD Billion to 1.75 USD Billion, respectively.
This growth is influenced by gradual improvements in healthcare access and technology adoption. Each region's unique economic landscape, regulatory frameworks, and healthcare demands play a vital role in shaping the Blood Testing Market revenue and segmentation.
This supports a holistic growth trajectory.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Blood Testing Market is characterized by a highly competitive landscape driven by an increasing demand for high-quality laboratory services and the growing prevalence of various diseases. This market offers significant opportunities for innovations in testing technologies.
This is particularly relevant with the advent of point-of-care testing and advancements in laboratory automation. With a wide range of applications, including disease detection, transfusion safety, and genetic testing, the market is witnessing a surge in demand across healthcare settings.
The presence of numerous players with varying degrees of market share further intensifies the competition, establishing a climate where companies continually seek to differentiate themselves through technological advancement, strategic partnerships, and improved patient outcomes.
Abbott Laboratories stands out in the Blood Testing Market due to its extensive product portfolio and robust presence in diagnostics. The company is known for its innovative blood testing systems that leverage advanced technology to provide rapid and accurate results.
This significantly enhances clinical decision-making. With a strong commitment to research and development, Abbott Laboratories has consistently introduced new products aimed at addressing emerging health challenges.
The company's strength lies in its integrated approach to diagnostics, allowing it to offer comprehensive solutions that cater to diverse healthcare needs. Abbott's established relationships with healthcare providers and its global distribution network further bolster its position in the market.
This ensures broad accessibility of its testing solutions.
Bio-Rad Laboratories Inc. is a significant player in the Blood Testing Market, known for its high-quality diagnostic products and clinical laboratory services. The company specializes in blood typing, quality control, and molecular biology.
It offers a range of essential products such as immunoassays and blood culture systems. Bio-Rad’s strengths lie in its commitment to innovation and quality, which have earned it a reputation for reliability among laboratories.
The company has a strong market presence globally, bolstered by strategic mergers and acquisitions that enhance its capabilities and product offerings. Through collaborations and partnerships, Bio-Rad continues to expand its reach, providing advanced solutions.
These solutions support healthcare professionals in delivering accurate and timely blood test results, thus solidifying its position in the competitive landscape of the Blood Testing Market.
Recent developments in the Blood Testing Market indicate significant advancements and increased activities among key companies. Abbott Laboratories and Thermo Fisher Scientific Inc. have introduced innovative blood testing solutions to enhance diagnostic accuracy and speed.
In October 2023, Becton Dickinson and Company announced the expansion of its automation capabilities for blood analysis, aimed at improving operational efficiency. Current affairs reflect a growing demand for rapid diagnostics due to the ongoing evolution of infectious diseases and chronic conditions.
This is pushing companies like Hologic Inc. and Roche Holding AG to invest heavily in Research and Development. Notably, in September 2023, Danaher Corporation completed the acquisition of GE Healthcare’s biomanufacturing business, which bolsters its presence in the healthcare space.
This includes blood testing. Additionally, Siemens Healthineers has expanded its pipeline of advanced analyzers through partnerships focusing on the integration of artificial intelligence. The overall market is witnessing a boost in valuation, driven by technological advancements and strategic collaborations.
Over the past two to three years, companies have reported a significant increase in demand for blood tests, with Mindray Medical International Limited recently highlighting a 25% growth in their testing solutions segment.
| Report Attribute/Metric | Details |
| Market Size 2023 | 27.66(USD Billion) |
| Market Size 2024 | 28.81(USD Billion) |
| Market Size 2035 | 45.1(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 4.16% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Kreative Technologies, Thermo Fisher Scientific, Grifols, PerkinElmer, Siemens Healthineers |
| Segments Covered | Test Type, End User, Product, Regional |
| Key Market Opportunities | Point-of-care testing expansion, Integration of AI diagnostics, Growth in preventive health screenings, Expansion in personalized medicine, Increased awareness and education |
| Key Market Dynamics | Rising chronic diseases, Increasing health awareness, Growing demand for point-of-care testing, Stringent regulatory environment |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Blood Testing Market Highlights:
Frequently Asked Questions (FAQ) :
The Blood Testing Market in 2024 was 28.81 USD Billion.
By 2035, the Blood Testing Market is projected to reach 45.1 USD Billion.
The expected compound annual growth rate (CAGR) for the market is 4.16% from 2025 to 2035.
The market value for Europe in 2024 was 7.5 USD Billion, expected to increase to 11.9 USD Billion by 2035.
The Blood Chemistry Tests segment was valued at 9.98 USD Billion in 2024.
The Complete Blood Count segment was valued at 5.76 USD Billion in 2024 and is expected to reach 11.5 USD Billion by 2035.
Major players in the market include Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories among others.
The market size for Complete Blood Count tests is expected to be 10.05 USD Billion in 2024.
The market for Blood Glucose Tests is expected to grow from 6.3 USD Billion in 2024 to 9.89 USD Billion in 2035.
By 2035, Coagulation Tests are expected to reach 4.4 USD Billion and Blood Typing Tests are projected at 3.03 USD Billion.
The Asia Pacific region shows significant growth potential with values expected to increase from 6.5 USD Billion in 2024 to 10.5 USD Billion in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
